Nordlandssykehuset HF — Clinical Trial Site

34 Registered trials

18 Currently recruiting

Organisation

Nordlandssykehuset HF

Location

Bodo, Norway

Identifier

ORG-100044267

Address

Parkveien 95, 8005, Norway

Departments

Avdeling for kreft og lindrende behandling
Barnepoliklinikken
Department of Cancer
Department of Cancer and Palliative Care
Department of Cardiology
Department of Infectious Diseases
Department of Nephrology
Department of Neurology
Department of Oncology
Department of Rheumatology, Medical clinic
Dept. of Neurology
Dept. of Oncology
Dermatology
Hematologisk avdeling
Hematology
Hjerteavdelingen
Kardiologisk avdeling
Medisinsk avdeling
Medisinsk avdeling, medisinsk poliklinikk K3
medisinsk poliklinikk K3
Neurology
Nordland Hospital Bodø
Nordlandssykehuset HF
Oncology
Pediatrics
Rheumatology department
Stroke

Clinical trials at this site (34)

Search interface

Episodic CandClus2: A randomized, placebo-controlled, triple blind study of candesartan in adults with episodic cluster headache Pending

2025-521470-34-00 episodic cluster headache 5
Chronic CandClus2: A randomized, placebo-controlled, triple blind crossover study of candesartan in adults with chronic cluster headache Pending

2025-521529-34-00 chronic cluster headache 5
A Multicenter, Randomized, Double-Blind, Active Comparator-Controlled, Adaptive Phase 2/3 Study to Evaluate the Safety and Efficacy of EIK10… Recruiting

2024-512659-19-00 Advanced Melanoma 10 2025-03-31
A Phase 2, Randomized, Double-Blind, Double-Dummy Study Evaluating the Efficacy, Safety and Biomarkers Effect of ILB® versus Riluzole in par… Recruiting

2024-513927-18-00 Amyotrophic Lateral Sclerosis 4 2026-02-16
A clinical study of sac-TMT in people with breast cancer (MK-2870-032) Recruiting

2024-520190-12-00 Breast Cancer: triple negative breast cancer (TNBC) and 5 2025-11-10
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
Antiplatelet therapy added to standard thromboprophylaxis to prevent thrombosis in pancreatic cancer patients - a randomized clinical trial … Recruiting

2023-509022-22-00 Pancreatic ductal cancer 5 2025-08-21
Comprehensive Evaluation of Two Second-Line Therapeutic Approaches for Immune Thrombocytopenia (ITP) – a Pragmatic Randomized Controlled Tri… Recruiting

2023-505573-32-00 Immune Thrombocytopenia (ITP) 5 2025-07-01
Aminoglycosides in early sepsis Recruiting

2024-519797-39-00 Sepsis 6 2025-07-01
Precision cancer medicine in hard-to-treat rare cancers - repurposing drugs in earlier lines of treatment - MATRIX-RARE. Recruiting

2024-513779-42-02 Cancer 4 2025-03-27
eHealth Based treatment of AdolescenT obesiTy with Low energy diet and sEmaglutide (eBATTLE Obesity) Recruiting

2023-506289-29-00 Obesity 6 2025-02-28
Effect of proactive therapeutic drug monitoring on maintenance of sustained disease control in adults with rheumatoid arthritis on a subcuta… Recruiting

2023-510184-35-00 Rheumatoid arthritis 6 2024-08-20
Painful Inflammatory Carpometacarpal-1 osteoArthritis treated with intraarticular Steroids, Saline or an Occupational therapy intervention: … Recruiting

2023-505254-17-00 Osteoarthritis in first carpometacarpal joint 6 2023-11-03
Tranexamic acid for hyperacute spontaneous IntraCerebral Haemorrhage (TICH-3) Recruiting

2022-500587-35-01 Stroke 5 2023-07-06
A Study of Subcutaneous Nivolumab + Relatlimab FDC in Previously Untreated Metastatic or Unresectable Melanoma (RELATIVITY-127) Recruiting

2022-500967-11-00 Previously Untreated Metastatic or Unresectable Melanom 5 2023-07-06
A Randomized Trial of Trastuzumab Deruxtecan and Biology-Driven Selection of Neoadjuvant Treatment for HER2-positive Breast Cancer Recruiting

2022-501504-95-00 Non-metastatic HER2-positive Breast Cancer 4 2023-06-23
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Patients With Stage III Unresectabl… Recruiting

2023-506891-28-00 The target population of interest in this study is part 5 2022-05-02
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
Improving public cancer care by implementing precision medicine in Norway Recruiting

2023-507894-16-00 Cancer 4 2021-04-01
The Norwegian Antibiotics for Pneumonia in Children (NAPIC) Study Recruiting

2024-512001-39-01 Lower respiratory tract infection 6 2018-02-01
A Study to Find Out How Safe and Effective AZD0780 Is for Adults with High 'Bad' Cholesterol from an Inherited Condition Ended

2025-520520-17-00 Heterozygous familial hypercholesterolaemia 5 2025-09-05
A Phase 2 Study of CAL101 in Patients with Idiopathic Pulmonary Fibrosis Ended

2024-518339-12-00 Idiopathic Pulmonary Fibrosis 4 2025-07-08
RElapse from Mrd Negativity As iNdication for Treatment Ended

2023-510215-18-00 Multiple myeloma 10 2024-09-26
Extension trial for adults with high cholesterol who completed a MK-0616 clinical trial Ended

2023-504922-20-00 Hypercholesterolemia 5 2024-08-23